Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Cystic Fibrosis Common Mutation Panel Institute for Genomic Medicine (IGM) Clinical Laboratory Nationwide Children's Hospital United States | 1 | 1 |
|
Carrier Screening - Comprehensive Panel (145 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States | 185 | 145 |
|
Molecular Genetics and Cytogenetics, Clinical Laboratory Service RED DE SALUD UC CHRISTUS Chile | 1 | 1 |
|
GeneID Lab - Advanced Molecular Diagnostics United States | 73 | 61 |
|
Cystic Fibrosis Diagnostic Mutation Michigan Medical Genetics Laboratories University of Michigan United States | 1 | 1 |
|
CFTR deletion/duplication analysis Michigan Medical Genetics Laboratories University of Michigan United States | 1 | 1 |
|
Michigan Medical Genetics Laboratories University of Michigan United States | 1 | 1 |
|
CFTR Targeted Mutation Analysis for Cystic Fibrosis Molecular Diagnostics Laboratory Duke University Health System United States | 1 | 1 |
|
Mayo Clinic Laboratories Mayo Clinic United States | 1 | 1 |
|
Cystic Fibrosis (CF) Mutation Panel Mayo Clinic Laboratories Mayo Clinic United States | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 243 | 238 |
|
Centogene AG - the Rare Disease Company Germany | 316 | 314 |
|
CFTR sequence of selected exons Genetics Service Unit BRIC-National Institute of Biomedical Genomics India | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 4 | 1 |
|
CFTR - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 4 | 1 |
|
TGFB1 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 3 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 323 | 329 |
|
Centogene AG - the Rare Disease Company Germany | 498 | 498 |
|
Centogene AG - the Rare Disease Company Germany | 499 | 499 |
|
Centogene AG - the Rare Disease Company Germany | 27 | 29 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.